← Open Payments lookup

GLENDA YBARRA: Open Payments

NPI 1063289056 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,797 in 116 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $710 · 2025 $2,797

Food & beverage: $2,797
CompanyPaymentsAmount
ABBVIE INC.33$641
Vanda Pharmaceuticals Inc.10$326
Otsuka America Pharmaceutical, Inc.10$323
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$300
Axsome Therapeutics, Inc.9$265
Corium, LLC9$217
Alkermes, Inc.9$209
Lundbeck LLC7$193
Takeda Pharmaceuticals U.S.A., Inc.6$141
Collegium Pharmaceutical, Inc.3$60

Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, Azstarys, HETLIOZ, FANAPT, ARISTADA.

Industry payments across FL — which companies pay providers there.